These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 35852861)
1. Pneumococcal Vaccination Recommendation and Completion Rates Among Patients With Inflammatory Bowel Disease and Barriers to Vaccination. Dasharathy SS; May FP; Myint A; Yang L; Rahal HK; Cusumano V; Kozan PA; Lowe SC; Beah PY; Limketkai BN; Sauk JS J Clin Gastroenterol; 2023 Nov-Dec 01; 57(10):1031-1037. PubMed ID: 36728018 [TBL] [Abstract][Full Text] [Related]
2. Improving Pneumococcal Vaccination Rates in Immunosuppressed Pediatric Patients with Rheumatic Disease. Harris JG; Jones JT; Favier L; Fox E; Holland MJ; Ivy A; Hoffart CM; Ibarra M; Cooper AM Pediatr Qual Saf; 2024; 9(3):e725. PubMed ID: 38751894 [TBL] [Abstract][Full Text] [Related]
3. Quality Improvement Interventions to Enhance Vaccine Uptake in Cancer Patients: A Systematic Review. Kazi B; Talukdar Z; Schriefer J J Healthc Qual; 2024 Mar-Apr 01; 46(2):81-94. PubMed ID: 38421906 [TBL] [Abstract][Full Text] [Related]
4. An overview of risk factors, management and prevention of cochlear implant infections. MacKay CI; Kuthubutheen J; Campbell AJ Curr Opin Infect Dis; 2024 Jun; 37(3):220-225. PubMed ID: 38545833 [TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016. Vila-Corcoles A; Hospital I; Ochoa-Gondar O; Satue E; de Diego C; Vila-Rovira A; Gómez-Bertomeu F; Raga X; Aragón M Vaccine; 2020 Jan; 38(5):1170-1180. PubMed ID: 31759735 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group. Svensson T; Kättström M; Hammarlund Y; Roth D; Andersson PO; Svensson M; Nilsson I; Rombo L; Cherif H; Kimby E Vaccine; 2018 Jun; 36(25):3701-3707. PubMed ID: 29748028 [TBL] [Abstract][Full Text] [Related]
7. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea. Heo JY; Seo YB; Choi WS; Lee J; Noh JY; Jeong HW; Kim WJ; Kim MJ; Lee HY; Song JY PLoS One; 2017; 12(5):e0177342. PubMed ID: 28498857 [TBL] [Abstract][Full Text] [Related]
10. Improving Pneumococcal Vaccination Rates in Cochlear Implant Programs: A Systematic Review and Meta-analysis. Britt AF; Poupore NS; Nguyen SA; White DR Otolaryngol Head Neck Surg; 2023 Mar; 168(3):291-299. PubMed ID: 35852861 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. Cripps AW; Folaranmi T; Johnson KD; Musey L; Niederman MS; Buchwald UK Expert Rev Vaccines; 2021 Mar; 20(3):257-267. PubMed ID: 33567914 [No Abstract] [Full Text] [Related]
12. Vaccination rates in cochlear implant patients: a review of paediatric recipients. Rose O; Moriarty R; Brown C; Teagle H; Neeff M J Laryngol Otol; 2022 Jul; 136(7):628-631. PubMed ID: 34698004 [TBL] [Abstract][Full Text] [Related]